Tekla Healthcare Investors
$20.64
297
+$0.15+0.73% Monday 22:28
Statistics
Day High
-
Day Low
-
52W High
21.84
52W Low
16.71
Volume
-
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
10.98%
Dividend
2.27
Upcoming
Dividends
10.98%Dividend Yield
Jun 26
$0.61
Mar 26
$0.63
Jan 26
$0.57
Sep 25
$0.51
Jun 25
$0.54
10Y Growth
1.15%
5Y Growth
2.61%
3Y Growth
13.19%
1Y Growth
5.94%
Earnings
7DecExpected
Expected EPS
0
Actual EPS
-1.64
Financials
956.56%Profit Margin
Profitable5.02MRevenue
48.03MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow XHQHX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
abrdn Healthcare Opportunities Fund
THQ
Mkt Cap0
abrdn Life Sciences Investors
HQL
Mkt Cap515.42M
Vanguard Health Care
VHT
Mkt Cap0
State Street Health Care Select Sector SPDR
XLV
Mkt Cap0
iShares U.S. Healthcare Providers
IHF
Mkt Cap0
VanEck Biotech
BBH
Mkt Cap0
Invesco Pharmaceuticals
PJP
Mkt Cap0
iShares U.S. Healthcare
IYH
Mkt Cap0
Fidelity MSCI Health Care Index
FHLC
Mkt Cap0
Blackrock Health Sciences Trust
BME
Mkt Cap529.11M
About
Abrdn Healthcare Investors is a closed-end equity fund, stewarded by abrdn Inc. Its mandate involves global public equity investments, specifically targeting the healthcare sector, encompassing businesses in biotechnology, medical devices, and pharmaceuticals. The primary focus is on high-growth, small-capitalization companies. The portfolio is constructed using a fundamental analysis approach, scrutinizing companies based on their current or projected market position for products and services, the experience of their management teams, their technological prowess, and their capability to either self-fund growth or secure external financing. Its performance is measured against several benchmarks: the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Established on October 31, 1986, the fund is domiciled in the United States.
Show more...
CEO
Dr. Daniel R. Omstead M.S, Ph.D.
Country
United States
Listings
0 Comments
Share your thoughts
FAQ
What is Tekla Healthcare Investors stock price today?▼
The current price of XHQHX is $20.64 USD — it has increased by +0.73% in the past 24 hours. Watch Tekla Healthcare Investors stock price performance more closely on the chart.
What is Tekla Healthcare Investors stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tekla Healthcare Investors stocks are traded under the ticker XHQHX.
Is Tekla Healthcare Investors stock price growing?▼
XHQHX stock has risen by +1.98% compared to the previous week, the month change is a -0.24% fall, over the last year Tekla Healthcare Investors has showed a +21.41% increase.
What is Tekla Healthcare Investors revenue for the last year?▼
Tekla Healthcare Investors revenue for the last year amounts to 5.02M USD.
What is Tekla Healthcare Investors net income for the last year?▼
XHQHX net income for the last year is 48.03M USD.
Does Tekla Healthcare Investors pay dividends?▼
Yes, XHQHX dividends are paid quarterly. The last dividend per share was 0.54 USD. As of today, Dividend Yield (FWD)% is 10.98%.
In which sector is Tekla Healthcare Investors located?▼
Tekla Healthcare Investors operates in the Finance & Payments sector.
When did Tekla Healthcare Investors complete a stock split?▼
The last stock split for Tekla Healthcare Investors was on August 26, 2015 with a ratio of 1.02248258391:1.
Where is Tekla Healthcare Investors headquartered?▼
Tekla Healthcare Investors is headquartered in Philadelphia, United States.